Toll Free: 1-888-928-9744
Published: Aug, 2014 | Pages:
34 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Adamas Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Adamas Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Adamas Pharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Adamas Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Adamas Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Adamas Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Adamas Pharmaceuticals, Inc.'s pipeline products Reasons to buy - Evaluate Adamas Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Adamas Pharmaceuticals, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Adamas Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Adamas Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Adamas Pharmaceuticals, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Adamas Pharmaceuticals, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Adamas Pharmaceuticals, Inc. Snapshot 5 Adamas Pharmaceuticals, Inc. Overview 5 Key Information 5 Key Facts 5 Adamas Pharmaceuticals, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Adamas Pharmaceuticals, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Combination Treatment Modalities 10 Adamas Pharmaceuticals, Inc. - Pipeline Products Glance 11 Adamas Pharmaceuticals, Inc. - Late Stage Pipeline Products 11 Pre-Registration Products/Combination Treatment Modalities 11 Phase III Products/Combination Treatment Modalities 12 Adamas Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Adamas Pharmaceuticals, Inc. - Early Stage Pipeline Products 14 Discovery Products/Combination Treatment Modalities 14 Adamas Pharmaceuticals, Inc. - Unknown Stage Pipeline Products 15 Unknown Products/Combination Treatment Modalities 15 Adamas Pharmaceuticals, Inc. - Drug Profiles 16 (memantine hydrochloride ER + donepezil hydrochloride) 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 amantadine hydrochloride ER 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 (amantadine + oseltamivir + ribavirin) 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 ADS-8800 Series 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 ADS-9000 Series 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Adamas Pharmaceuticals, Inc. - Pipeline Analysis 23 Adamas Pharmaceuticals, Inc. - Pipeline Products by Target 23 Adamas Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 24 Adamas Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 25 Adamas Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 26 Adamas Pharmaceuticals, Inc. - Recent Pipeline Updates 27 Adamas Pharmaceuticals, Inc. - Dormant Projects 31 Adamas Pharmaceuticals, Inc. - Locations And Subsidiaries 32 Head Office 32 Appendix 33 Methodology 33 Coverage 33 Secondary Research 33 Primary Research 33 Expert Panel Validation 33 Contact Us 34 Disclaimer 34
List of Tables Adamas Pharmaceuticals, Inc., Key Information 5 Adamas Pharmaceuticals, Inc., Key Facts 5 Adamas Pharmaceuticals, Inc. - Pipeline by Indication, 2014 7 Adamas Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8 Adamas Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9 Adamas Pharmaceuticals, Inc. - Combination Treatment Modalities in Pipeline, 2014 10 Adamas Pharmaceuticals, Inc. - Pre-Registration, 2014 11 Adamas Pharmaceuticals, Inc. - Phase III, 2014 12 Adamas Pharmaceuticals, Inc. - Phase II, 2014 13 Adamas Pharmaceuticals, Inc. - Discovery, 2014 14 Adamas Pharmaceuticals, Inc. - Unknown, 2014 15 Adamas Pharmaceuticals, Inc. - Pipeline by Target, 2014 23 Adamas Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 24 Adamas Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 25 Adamas Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 26 Adamas Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 27 Adamas Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 31
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.